AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression

被引:9
|
作者
Ma, Peng [1 ]
Hao, Ying [1 ]
Wang, Wei [1 ]
Zhang, Yue-Feng [1 ]
Yu, Kai-Huan [1 ]
Wang, Wei-Xing [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary Surg, Wuhan 430060, Hubei, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; CHOLANGIOCARCINOMA; SURVIVAL;
D O I
10.1007/s12672-023-00707-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrahepatic cholangiocarcinoma (ICC) is a fatal disease and the molecular mechanism of its progression remains unknown. Aurora Kinase B (AURKB) is a central regulator of chromosome separation and cytokinesis and is abnormally expressed in a variety of cancer cells. This research aimed to explore the effect of AURKB in occurrence and metastasis of ICC. We found that AURKB showed a progressive up-regulation pattern from normal bile duct tissue to ICC with high invasion. Our data showed that AURKB significantly promoted ICC cell proliferation, induced epithelial-mesenchymal transition (EMT), migration and invasion through gain- and loss- of function experiments. In vivo results consistently showed that AURKB up-regulation not only promoted tumor growth, but also promoted tumor metastasis. Importantly, we discovered that AURKB regulates the expressions of EMT-related genes via PI3K/AKT signaling axis. Herein, our results suggest that AURKB induced EMT through the activation of PI3K/AKT signaling pathway is critical to the progression of ICC, which may be a prospective therapeutic treatment for overcoming ICC metastasis and progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway
    Wang, Yadong
    Fang, Xiaosan
    Xie, Hao
    Wang, Xiaoming
    BIOCHEMICAL GENETICS, 2024,
  • [32] Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
    Chen Xue
    Ganglei Li
    Juan Lu
    Lanjuan Li
    Signal Transduction and Targeted Therapy, 6
  • [33] Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
    Liu, Yanhui
    Kong, Haobo
    Cai, Heping
    Chen, Guanru
    Chen, Huiying
    Ruan, Wenyi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] TSPAN31 Activates Fatty Acid Metabolism and PI3K/AKT Pathway to Promote Tumor Progression in Breast Cancer
    Luo, Wenquan
    Sun, Yuxiang
    Cao, Liang
    MOLECULAR CARCINOGENESIS, 2025,
  • [35] PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
    Deng, Shuo
    Leong, Hin Chong
    Datta, Arpita
    Gopal, Vennila
    Kumar, Alan Prem
    Yap, Celestial T.
    CANCERS, 2022, 14 (07)
  • [36] Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
    Xue, Chen
    Li, Ganglei
    Lu, Juan
    Li, Lanjuan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [37] P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway
    Wu, Yan-Ling
    Liu, Wan
    Zhao, Tingting
    Jin, Jing
    MEDICAL ONCOLOGY, 2024, 41 (06)
  • [38] Targeting of PI3K/AKT and MEK Signaling
    de Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S84 - S84
  • [39] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [40] PI3K/AKT signaling and systemic autoimmunity
    Patel, RK
    Mohan, C
    IMMUNOLOGIC RESEARCH, 2005, 31 (01) : 47 - 55